New drug RPT1G tested in humans for first time
Knowledge-focused
Completed
This early-stage trial tested the safety of a new oral drug, RPT1G, in 56 healthy adults. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. Since this is a first-in-human study, it does not aim to t…
Phase: PHASE1 • Sponsor: Remedy Plan, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:22 UTC